A carregar...
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
PURPOSE: To evaluate the cytotoxicity of varying doses of Bevacizumab on corneal endothelial cells in the presence of a range of concentrations of vascular endothelial growth factor (VEGF). Bevacizumab, a drug widely used in the treatment of neovascular glaucoma neutralizes all isoforms of VEGF and...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Molecular Vision
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3247162/ https://ncbi.nlm.nih.gov/pubmed/22219629 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|